By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week, March 15-19, is right around the corner! The 5-day digital partnering event consists of three conferences focusing on different areas within life science and healthcare. Redefining Early Stage Investments (RESI) broadly covers investor insights for fundraising executives within healthtech, biotech, and medtech. 4D Meets AI specifically tackles the investor-founder relationship, from pitch to partner, while working with AI technology in drugs, devices, diagnostics, and digital health (4Ds). Longevity, Health & Innovation, co-organized with Mary Furlong & Associates, provides a big-picture approach to the investment ecosystem, as well as market overview and regulatory landscape for early-stage age-tech and innovation enabling seniors to live longer, better lives.

Life Science Nation (LSN) is pleased to introduce our preliminary speaker lineup, featuring investors and industry experts sharing their experiences and offering insights to help fundraising companies succeed in the early stages.

Interested in joining a panel? Visit www.healthtechpartneringweek.com to learn more about each conference. Fundraising in 2021, and looking to meet with active investors? Join us and save on our early-bird rates by February 19!

Featured Healthtech Partnering Week Panelists

Sascha Berger Partner TVM Capital Life Science Diagnostics	Jean Anne Booth CEO UnaliWear Inc. Devices	Nat Brinn Partner VC23 Tools and R&D Services	Barbara Clarke Founder & President The Impact Seat Investing in New, Now, and Next
Evan Cohen Associate Principal, Strategic Investing Healthbox Digital Health for the Elderly	Michele Colucci Managing Partner DigitalDx Ventures Diagnostics	Terence Craig Chief Investment Officer The Impact Seat Devices	Bettina Ernst Director BERNINA BioInvest Investing in New, Now, and Next
Howard Fillit Founding Executive Director and CSO Alzheimers Drug Discovery Foundation Early Detection of CNS Disorders	Robert Garber Partner 7wire Ventures Investing in New, Now, and Next	Amit Garg Managing Partner Tau Ventures Digital Health	Scott Gazelle Managing Partner GreyBird Ventures Diagnostics
Tom Gibbs Director Debiopharm Innovation Fund Digital Health	Katherine Hill Ritchie Director Nottingham Spirk Family Office Medical Devices	Alicia Irurzun-Lafitte Partner UCB Ventures Cell & Gene Therapy	Justin Kelly Associate AXA Venture Partners Digital Health for the Elderly
Oliver Keown Director, Intuitive Ventures Intuitive Surgical Combination Devices	Lily Kim Scientific Director OS Fund Tools and R&D Services	Kristin King Member Boston Harbor Angels Medical Devices	Richard Kivel Managing Director GrayBella Capital Diagnostics
Daniella Kranjac Founding Partner Dynamk Capital Tools and R&D Services	Taja Lester Managing Partner Health Equity Capital Digital Health for the Elderly	George Li Managing Partner Proxima Ventures Diagnostics	Jonathan Ng CEO Iterative Scopes Digital Health
Jeffrey Ries Managing Director Healthbox Digital Health	Kerry Rupp General Partner True Wealth Ventures Digital Health for the Elderly	Chirag Shah Principal Define Ventures Digital Health	Patrik Sobocki Investment Manager Life Science Industrifonden Digital Health
Catello Somma Associate TVM Capital Life Science Early Stage Therapeutics	Weiyong Sun Senior Director, Specialty Medicine Search & Evaluation Daiichi Sankyo Cell & Gene Therapy	Tad Weems Managing Director Agilent Technologies Tools and R&D Services

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation (LSN)’s mission is to connect early-stage companies in life science and healthcare with investment capital that is a fit based on product and stage of development. LSN’s partnering system is unique in that it contains search functionality to help fundraising executives narrow down to the best investors for their needs, removing the question, “Is this a good fit?”

While LSN cannot make the deal for you, we can help you connect with the contacts you need to succeed in your raise and growth. We can also prepare you with tried-and-true tips to make your partnering experience exceptional, letting your technology, product, and team take center-stage as you pitch to investors.

Sign up for our free webinar, Strategies for Successful Partnering, taking place February 17, 12 PM EST. Whether Seed or Series B, our methods have assisted early-stage companies in raising millions of dollars, and we hope to add yours to our growing list of success stories!

Are you fundraising and looking to meet with investors who fit your product set and stage of development? Sign up for Healthtech Partnering Week, March 15-19, by February 19 to save on early-bird rates!

By Gregory Mannix, Vice President International Business Development, LSN

Patrik Frei, PhD CEO Venture Valuation

Gergely Ivanyi, PharmD Business Analyst Venture Valuation

Elias Neuendorf, MSc Business Analyst Venture Valuation

Company Valuation for Fundraising

Instructors: Patrik Frei, PhD, CEO, Venture Valuation
Gergely Ivanyi, PharmD, Business Analyst, Venture Valuation
Valuation is a key aspect of fundraising. An average value assumption for each company in a specific financing stage just does not do it anymore. For entrepreneurs, as for investors, it’s important to understand the value drivers of a company. We are looking at the financing trends of the last years, discuss dos and don’ts when speaking with investors and look at how to value a life science company with no revenues.

Topics include, but are not limited to:

• • Overview financing trends

• Which is the right investor?
• Dos and don’ts
• Company valuation approaches

Product Valuation for Deal-Making

Instructors: Patrik Frei, PhD, CEO, Venture Valuation
Elias Neuendorf, MSc, Business Analyst, Venture Valuation
Companies looking at in- or out-licensing need to understand the value dynamics of their product to negotiate realistic deal-terms. Successful business development depends on understanding the fundamentals as well as keeping up with the latest licensing deal trends. We will be looking at the latest deals including up-front and total deal values for different stages and indications and discuss the fundamental valuation approach to asset/product valuation as a basis to estimate possible licensing deal terms.

Topics include, but are not limited to:

• Overview licensing deal and trends
• How to find the right licensing partner
• Asset/Product valuation approach
• Licensing deal negotiation

If you’re interested in hosting a workshop or panel at Healthtech Partnering Week, our Business Development Team is happy to learn more in order to meet your goals. Contact us to start the conversation!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Healthtech Partnering Week, the premier partnering experience for early-stage companies innovating life science and healthcare, is fast approaching! We are thrilled to announce the schedule for the week. If you haven’t signed up yet, there’s still time to save on early bird rates – sign up by February 19 to save and start meeting your fundraising goals!

Check Out Our Live Panel Schedule for Healthtech Partnering Week, March 15-19

Digital RESI

Digital Redefining Early Stage Investments (RESI) is Life Science Nation’s flagship partnering event, featuring active, early-stage investors across biotech, medtech, and healthtech. RESI seeks to highlight the latest investment trends in order to advance cross-border, cross-domain partnerships.

4D Meets AI

4D Meets AI panels host active investors and their portfolio companies to discuss funding, partnerships, and the future of AI in each one of the 4Ds: drugs, devices, diagnostics, and digital health.

Longevity, Health & Innovation

Longevity, Health & Innovation features two tracks: Investment Ecosystem and Market Overview. The panels, co-organized with Mary Furlong & Associates are designed to provide a whole picture of the longevity marketplace, focusing on early-stage investments and strategic partnerships, as well as technology, innovation, regulation, and advancements in the field.

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

Life Science Nation (LSN) is ramping up its partnering theme for 2021 by emphasizing global roadshow preparation for the 4,500 fundraising CEOs and scientist-entrepreneurs at our cross-border, cross-domain, digital partnering events. LSN’s infrastructure is designed to help early-stage companies prepare for the capital and partnering journey with products and services including, but not limited to:

• Two databases: Investor Platform with 10,000 global investors and strategic partners, and Company Platform with 60,000 life science companies.
• 300+ university, regional, and governmental tech hubs that use LSN partnering events to help their local technology companies get global exposure.
• Growing global super-structure consisting of a cross-border, cross-domain, two-way bridge for licensing and funding life science technology assets.
• Quarterly Healthtech Partnering Week (HPW), consisting of three partnering conferences: RESI, 4D Meets AI, and Longevity, Health & Innovation (co-organized with Mary Furlong & Associates), that further develops our global footprint as a major force in connecting buyers and sellers in the international arena.
• Focus on Cures Accelerator for sourcing, vetting, developing and preparing key companies for global licensing and fundraising campaigns.
• I-Bank, Boston Innovation Capital, for licensing and funding campaigns for elite healthcare technology companies internationally.

LSN has invested 8 years in building out this global network, and our 2021 growth will serve as a compass toward the future. We look forward to developing our products, services, as well as deep alliances with the global players leveraging this unique golden age of life science, where breakthrough and game-changing technology is in no short supply.

By Rory McCann, Marketing Manager & Conference Producer, LSN

Life Science Nation (LSN)’s Healthtech Partnering Week, March 15-19, 2021, has announced its agenda, and we hope you’ll consider taking part! Whether you are a fundraising CEO, scientist-entrepreneur, service provider, regional tech hub, or investor, there are ways to get involved and take advantage of the weeklong partnering event by attending, speaking, pitching, sponsoring, or exhibiting.

Investors

Digital Redefining Early Stage Investments (RESI) is a powerful gathering focused on early-stage funding across all verticals of life science. One of its strongest connection tools is its live investor panels offering insights into the early-stage fundraising process. If you’re an investor working with companies developing cutting edge biotech, medtech, and healthtech advancing the power and potential of healthcare and medicine, apply to join a panel at RESI.

4D Meets AI is hosting panels where active investors are joined by their portfolio companies to discuss funding, partnerships, and the future of AI in life science and healthcare. Join us for four live panels, each delving into one of the 4Ds: drugs, devices, diagnostics, and digital health. If you’re an investor in AI in healthcare and have a portfolio company to highlight, apply to participate on a 4D Meets AI panel.

Investors seeking opportunities in age-tech and longevity is a powerful and growing community. If you work with companies developing technology to advance Senior Care, Cardiovascular Disease, Oncology, Central Nervous System (CNS) Disease, Diabetes, Chronic Respiratory Disease (CRD), Hearing Loss & Sight Deterioration, Arthritis, or Mental Health Conditions, apply to join the conversation at Longevity, Health & Innovation.

Early-Stage Companies

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies actively raising seed capital (25K-2MM), Series A (2MM-10MM), or Series B (10MM-50MM) to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

Companies can learn more and apply for each Healthtech Partnering Week conference:

• Digital RESI
• 4D Meets AI
• Longevity, Health & Innovation

Tech Hubs

Tech hubs are invited to offer constituents to participate in Healthtech Partnering Week with special offers specifically for them. Constituents can save 50% on registration and receive a free dedicated landing page for optimal exposure on the conference Live Agenda. Additionally, LSN hosts partnering webinars to help CEOs make strong connections with 350+ healthcare investors, including a training workshop to help CEOs seeking financing to move their technologies forward in the development process.

Service Providers & Strategic Partners

Sponsorship helps companies gain visibility in the early-stage life science community by leveraging our close-knit network of key decision-makers to make promising connections. If you fall into any of these categories, LSN’s Business Development team would like to connect to share how Healthtech Partnering Week can help you meet your goals:

• Global investors, channel partners, strategic partners and big pharma sourcing technology assets for their pipeline, channels and new silos
• Service providers selling their services to funded CEOs, establishing relationships with global strategic partners and expanding market presence.
• Investors expanding their portfolio through technology assets, finding investment partners for joint deal syndication, and finding service providers to help develop their portfolio.

View our complete offerings in the Sponsorship Brochure and let us know how our dedicated team can add value to your sponsorship experience.